GL1X · GenesisL1 explorer

MolNFT v1 · #106039 · protein

Structure of prethrombin-2 mutant S195A bound to the active site inhibitor argatroban

4RN6 · Thrombin heavy chain: “Structure of prethrombin-2 mutant S195A bound to the active site inhibitor argatroban”. X-ray diffraction, 1 ligand (15U), 9 pockets (best druggability 0.71). MolNFT v1 #106039 on GenesisL1: 3D structure…

PDB
4RN6
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin heavy chain
EC
3.4.21.5
UniProt
P00734
Ligands
15U
Pockets
9 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BThrombin heavy chain (EC 3.4.21.5)protein28418% helix, 27% strandP00734

Ligands and binding sites

  • 15U · (2R,4R)-4-methyl-1-(N~2~-{[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-arginyl)piperidine-2-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15240.710.806715U
24080.670.805215U
3630.560.8815empty
4540.540.8916empty
51040.510.8221empty

Interfaces

1 interface between chains.

  • A–B · 693 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 4RN6 · Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban · the same entry in another collection · chain B against B, TM-score 1.00
  • P00734 · AlphaFold monomer V2.0 prediction for prothrombin (P00734) · a predicted model of the same protein · chain B against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.